HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer.
de Moura Leite L, Cesca MG, Tavares MC, Santana DM, Saldanha EF, Guimarães PT, Sá DDS, Simões MFE, Viana RL, Rocha FG, Loose SK, Silva SF, Pirolli R, Fogassa CAZ, Mattos BRS, Campos FAB, Sanches SM, de Lima VCC, Pondé NF.
de Moura Leite L, et al. Among authors: de lima vcc.
Breast Cancer Res Treat. 2021 Nov;190(1):155-163. doi: 10.1007/s10549-021-06365-7. Epub 2021 Aug 18.
Breast Cancer Res Treat. 2021.
PMID: 34409551